T he T cell repertoire has been evolutionarily selected for reactivity against foreign Ags presented by self MHC molecules. Endowment of T cells with such a repertoire is based on their expression of TCR␣ and ␤ chains on immature thymocytes expressing both CD4 and CD8 coreceptors (DP). 4 This is followed by a differentiation step toward mature, "single positive" (SP) thymocytes that is coordinated with a selection process that ensures that CD4 or CD8 T cell lineage cells have potential for reactivity with peptides bound to MHC class II and class I molecules, respectively. Thus, for a given thymocyte to be selected at the DP stage, TCR engagement with appropriate avidity is required to escape cell death either by neglect or by negative selection. Within the range of avidities compatible with positive selection, it is not yet clear which parameter is determining for the commitment and differentiation to CD4 or CD8 SP thymocytes (1, 2) . Recent studies have suggested that a critical parameter is the strength/duration of TCR engagement (1, 2) . The question as to whether lineage commitment is totally dependent on or can be dissociated from, thymocyte selection is also still debated (3, 4) . In addition to TCR interactions, other receptor-ligands have been suggested to play a role in determining thymocyte commitment. These include the Notch family members (5) (6) (7) (8) , as well as some transcription factors (9, 10) . In particular, the transcriptional repressor, Gfi1, was shown to favor CD8 thymocyte lineage selection (11) , possibly through its control of the expression of the E box protein, E47, which was also shown to influence CD4/CD8 lineage decision (12) . The expression of an antagonist of the transcription factor, GATA-3 (ROG), also favors CD8 SP and inhibits CD4 SP thymocyte development (10) .
Adaptive immunity thus benefits from these complex thymic processes to ensure that the T cell repertoire is prepared to react to most infectious agents while remaining tolerant to self components. T cell reactivity toward tumor Ags poses a particular case in that many of the identified tumor-associated Ags correspond to self MHC-associated peptides derived from nonmutated self-proteins. Two major types of such Ags have been identified that derive from 1) tissue-specific differentiation Ags or 2) a class of "cancer-germline" gene products, that, akin to the first identified MAGE gene, are encoded on the X chromosome and have restricted expression in gametogenic tissue and tumor cells (reviewed in Refs. 13 and 14) . In the mouse, the P1A Ag (15) characteristic of such cancergermline genes, has been shown to be the major rejection Ag of mastocytoma P815 in DBA/2 mice (16) and is known to encode a nonapeptide presented by L d to CD8 CTL that can kill P815 cells (17) . As a tool to trace CD8 T cell reactivity toward the model cancer-germline Ag P1A, we generated mice expressing as a transgene the TCR (TCRP1A) from P1A-specific CTL clone P1.5 of DBA/2 origin (17). We were struck by the poor selection of the TCRP1A CD8 T cells on the DBA/2 background. We further observed that upon backcrossing to the B10.D2 background, selection of TCRP1A CD8 T cells was improved. It was thus possible that the strain of origin provided a particularly poor selection context for the P1A-specific TCR. This possibility was investigated in radiation chimeras where TCRP1A bone marrow (BM) precursors differentiated in
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either DBA/2 or B10.D2 recipients. Our results reveal a hemopoietic cell-autonomous difference in differentiation patterns of TCRP1A thymocytes, independent of the thymic microenvironment, and controlled by DBA/2 vs B10.D2-encoded genes. The particularly poor selection of the MHC class I-restricted TCRP1A in DBA/2 mice therefore appears unrelated to its specificity, but rather highlights strain-dependent differences in thymocyte differentiation.
Materials and Methods

Mice
Mice heterozygous for the L d /P1A-specific TCR transgene (TCRP1A) on the DBA/2, B10.D2, and RAG-1°/°B10.D2 backgrounds (TCRP1A DBA/2, B10.D2, and RAG-1°/°B10.D2, respectively), nontransgenic littermates (non-tg), wild-type DBA/2 (Charles River Breeding Laboratories, Les Oncins, France), and B10.D2 mice (Harlan France SARL, Gannat, France) were bred in the animal facility of the Centre d'Immunologie de Marseille-Luminy (Marseille, France). Five-to 8-wk-old mice were used for the experiments.
Generation and identification of TCRP1A transgenic mice
The cDNA encoding the ␣ and ␤ chains of the TCR from P1A-specific CTL clone P1.5 of DBA/2 origin (17) were cloned in a previously established cassette vector (18) kindly provided by C. Benoist (Harvard Medical School, Boston, MA). Two founder mice were generated in a mixed background with proper integration of both TCR␣ and ␤ chain cDNAs. They were backcrossed for two generations on B10.D2, and further either on B10.D2 or DBA/2 wild-type or RAG-1°/°B10.D2 mice for more than six generations (see Fig. 1 ). Data presented concern only line 29TCRP1A, hereafter referred to as TCRP1A. Transmission of the transgenes to subsequent generations was ascertained by PCR using a set of primers: V␣8 (5Ј-GAATTCATGCGTCCTGGCACCTGC-3Ј) and J␣10 (5Ј-ACCAG CAATCGAGTCCCACTTCCA-3Ј), or V␤1 (5Ј-GAATTCATGAGCTG CAGGCTTCTC-3Ј) and J␤1.2 (5Ј-AAAAGCCTGGTCCCCGACCGA AG-3Ј), and by cytofluorimetry on blood lymphocytes using anti-V␣8.3 mAb or H-2L d tetramers refolded in the presence of the P1A nonameric peptide, LPYLGWLVF (L d /P1A tetramer), and based on a scaffold of biotin-streptavidin-PE as described (19) .
Cell preparation
Cells were prepared from thymus and lymph nodes (LNs) according to standard procedures. PBL were prepared from heparinized blood using Ficoll-Paque PLUS lymphocyte isolation kit (Amersham Biosciences, Uppsala, Sweden). Splenocyte preparations were depleted of RBCs by 0.83% NH 4 Cl treatment.
Radiation BM chimeras
Adult B10.D2 or DBA/2 mice were gamma irradiated (10 Gy from a 137 Cs source) and reconstituted 1 day later (i.v.) with T-depleted 1 ϫ 10 7 BM cells from TCRP1A DBA/2 or B10.D2 mice individually "single chimeras" or as a mixture in the ratio B10.D2:DBA/2 ϭ 1:2 or 1:4 for the "double chimeras". T-depleted BM cells were obtained after treatment with 0.83% NH 4 Cl followed by an Ab-mediated complement lysis using an antiThy1.2 Ab (JIJ). Thymocytes and LN were analyzed by flow cytometry at least 6 wk after reconstitution.
Flow cytometry analyses
Abs used for surface immunofluorescence staining were: FITC-labeled anti-CD4, anti-CD69, anti-CD25, anti-CD44, anti-CD62L, anti-CD24, and anti-CD5.1, PE-labeled anti-CD4 and anti-V␣8.3, PerCP-Cy5.5-labeled anti-CD8␣, and APC-labeled anti-CD4, anti-CD8␣, anti-CD3, and anti-CD5 (BD PharMingen, San Diego, CA). Triple or quadruple staining was done by incubating 1 ϫ 10 6 cells with a desired combination of the indicated Abs for 30 min at 4°C. After two washes, cells were fixed in 1% paraformaldehyde and run on a FACSCalibur cytofluorometer (BD Biosciences, Mountain View, CA). Data were analyzed using CellQuest (BD Biosciences) or FlowJo software (Treestar, Ashland, OR).
Statistical analysis
The comparison of mean values between groups was analyzed using GraphPad Prism (GraphPad, San Diego, CA). One-way ANOVA was performed to evaluate the statistical significance of the differences between the test groups. Values of p Ͻ 0.05 were considered to be statistically significant.
Results
Non-MHC genes affect the representation of CD8 T cells expressing the TCRP1A in peripheral organs of TCRP1A transgenic mice
Mice expressing the TCRP1A␣ and ␤ cDNAs were obtained in mixed background mice. One founder was backcrossed for two generations on B10.D2 and further either on B10.D2, DBA/2, or RAG-1°/°B10.D2. The distribution of CD4 vs CD8 T cells in the LNs of non-tg mice shows that DBA/2 mice have a higher ratio of CD4 to CD8 T cells in the periphery, as previously reported (20) . In the TCRP1A mice on the B10.D2 background, this CD4/CD8 ratio was decreased, as expected when a MHC class I-restricted TCR is expressed as a transgene (21) (22) (23) (24) . In contrast, in the DBA/2 background, the CD4/CD8 ratio was even slightly increased in mice expressing the TCRP1A tg (Fig. 1a) . Furthermore, the analysis of TCRP1A expressing CD8 T cells by anti-V␣8.3 or L d /P1A tetramer staining (Fig. 1b) showed that a higher percentage of LN CD8 T cells expressed the ␣␤ TCRP1A chains in the B10.D2 background mice, as compared with the DBA/2 background. Control CD8 T cells from non-tg mice did not bind L d /P1A tetramer and fewer than 15% expressed V␣8.3 (Fig. 1b) . CD4 LN T cells from TCRP1A mice on either B10.D2 or DBA/2 backgrounds failed to bind L d /P1A tetramers (results not shown). Furthermore, when we crossed tg mice with RAG-1°/°B10.D2 mice, which do not have endogenous TCR ␣␤ chains, LNs from such mice contained only CD8 T cells, 95% of which expressed the L d /P1A binding TCR (Fig. 1b) . These results are consistent with an exclusive selection on the CD8 lineage for the TCRP1A.
Analysis of surface markers on the TCRP1A-positive LN CD8 T cells indicates that they are naive (absence of CD44, CD69, and CD25, and presence of CD62L; results not shown) in both B10.D2 or DBA/2 mice.
Altogether, both the proportion of CD8 T cells and the representation of a particular class I-restricted TCR, TCRP1A, were defective in DBA/2 as compared with B10.D2 mice. The same observation was made when PBLs or splenic populations were studied (results not shown). Examination of F 1 mice (litter from mice after four backcross generations on B10.D2 crossed with DBA/2 mice; Fig. 1 , a and b) showed an intermediate phenotype suggesting that no dominant negative effect of DBA/2 genes was involved.
To understand what factors may lead to the poor representation of this tumor Ag-specific TCR in the strain in which it was originally selected, we next analyzed thymocyte subpopulations.
Non-MHC genes influence thymic commitment/selection of CD8 SP thymocytes expressing the TCRP1A
Thymic cellularity in TCRP1A mice was similar on B10.D2 or DBA/2 backgrounds, and consistently higher than that in non-tg control mice (Fig. 2a) . CD8 vs CD4 dot plots showed a relative enrichment in CD8 SP over CD4 SP thymocytes in TCRP1A B10.D2 mice as compared with non-tg B10.D2 littermates (2.8-fold in the experiment shown in Fig. 2a ; 3.4-fold for the mean values shown in Table I ). In absolute cell numbers, there was about a 5.5-fold increase (for the mean values shown in Table I ; 3.5-fold for the experiment shown in Fig. 2a ) in CD8 SP thymocytes in TCRP1A tg as compared with non-tg B10.D2 littermates. On the DBA/2 background, such increase in the number of CD8 SP thymocytes in TCRP1A mice as compared with non-tg mice was much less pronounced (1.65-fold for the mean values shown in Table I ; 1.01-fold for the experiment shown in Fig. 2a ). The number of CD8 SP thymocytes for the F 1 mice was intermediate between that of the two parental TCRP1A strains, and all of the TCRP1A mice had a similar number of CD4 SP thymocytes (Table I ). d /P1A tetramer staining on CD8 SP, DP, and CD4 SP thymocyte subpopulations. A striking difference appeared in the DP population where expression of the tg TCR was higher and more homogeneous in the DBA/2 as compared with the B10.D2 strain, whereas the pattern on the F 1 thymocytes was intermediate (data not shown). In both strains, V␣8.3 was expressed at a high level on CD8 SP and at a lower level on the CD4 SP thymocytes, whereas L d /P1A-binding was high on CD8 SP and negative on CD4 SP (Fig. 2b) . No L d /P1A-staining could be detected on non-tg control thymocytes of either strain of mice (results not shown; Fig. 2c) To further analyze the pattern of expression of the L d /P1A-binding TCR on transitional thymocyte subpopulations, thymocytes with different levels of L d /P1A staining were analyzed for CD4 vs CD8 expression (Fig. 2c) . Gating on the "low L d /P1A-binding" thymocytes (first dot plot in Fig. 2d ) revealed that they were mostly DP with a small proportion of CD4 ϩ CD8 Ϫ thymocytes in both mouse strains. The latter having the phenotype of CD4 SP thymocytes probably correspond to a contamination of that fraction by "very low to negative" L d /P1A-binding cells. The adjacent population of "intermediate (int)/high L d /P1A-binding" thymocytes (second dot plot in Fig. 2d ) contained DP thymocytes in both strains with a significant proportion of CD8 SP thymocytes only in B10.D2 mice. When gating was on high L d /P1A-binding thymocytes (third dot plot in Fig. 2d ), the proportion of CD8 SP thymocytes increased to 12% in B10.D2, whereas it remained low (1.4%) in DBA/2 mice, where most of the "high L d /P1A-binding" thymocytes were DP.
To evaluate the proportion of L d /P1A-binding thymocytes that were in a process of TCR-mediated selection, we monitored surface expression of CD69 since this marker has been found to be up-regulated on both "positively" and "negatively" selected thymocytes (25) . As shown in Fig. 2e , CD69 was expressed on a higher proportion of Ld/P1A int/high thymocytes in B10.D2 as compared with DBA/2 mice. This was true for all thymocyte subpopulations tested (CD8 SP, CD8 ϩ CD4 low , and DP). Because the expression of the tg TCR␣ chain and staining with L d /P1A do not necessarily reveal total level of TCR/CD3 (if endogenous TCR␣ chains are expressed), we further analyzed the level of CD3 on thymocyte subpopulations in TCRP1A tg B10.D2 and DBA/2 mice. Data showed that the level of CD3 was consistently lower on the B10.D2 as compared with DBA/2 DP thymocytes (data not shown). As with L d /P1A staining, both CD3 int and CD3 high thymocytes were characterized by a lower ratio of CD8 SP to DP thymocytes in DBA/2 as compared with B10.D2 mice (data not shown). Furthermore, CD3 vs L d /P1A-tet binding plots showed a diagonal distribution on DP thymocytes for both TCRP1A tg mouse strains (data not shown), and failed to detect CD3 high L d / P1A low thymocytes, which would identify thymocytes with endogenous TCR␣ expression, preferentially in one of the tg strains.
Altogether, these results suggest that in DBA/2 mice, the TCRP1A/CD3 is expressed at a high level on DP thymocytes, but that the selection process is inefficient in that strain. Although the TCRP1A (N4.B10.D2 ϫ DBA/2)F 1 presented an "intermediate" phenotype (data not shown), this mouse presents a mixed genetic make up in both hemopoietic and stromal cells and it is not clear which component provides the partial correction of the phenotype. To distinguish whether the poor selection observed in the DBA/2 strain was to be attributed to stromal thymic components or was intrinsic to cells of hemopoietic origin, a series of BM radiation chimeras was analyzed. 
Differential regulation of TCRP1A expression in DP thymocytes is intrinsic to hemopoietic, not to stromal components
Four types of chimeras were made by transfer of T cell-depleted BM from TCRP1A (DBA/2) or TCRP1A (B10.D2) mice in either DBA/2 or B10.D2 lethally irradiated recipient mice. Analysis of CD4 vs CD8 expression on thymocytes indicates that TCRP1A (B10.D2) BM precursors generate a lower CD4/CD8 SP thymocyte ratio than TCRP1A (DBA/2) BM precursors whether they differentiate in B10.D2 or in DBA/2 hosts (Fig. 3a) .
As no differences appeared at the DN checkpoint (results not shown), we further analyzed DP, SP, and transition populations with respect to expression of TCRP1A and V␣8.3 to assess whether the genetic make up of the thymic stromal cells might affect any thymocyte differentiation or commitment pattern.
The higher level of expression of V␣8.3 and L d /P1A-binding TCR on DP thymocytes was characteristic of the origin of the TCRP1A tg BM, being high for BM of DBA/2 origin (Fig. 3b , second panel) and low for BM of B10.D2 origin (Fig. 3b, third  panel) .
In radiation chimeras reconstituted with DBA/2 TCRP1A tg BM, the proportion of total thymocytes expressing TCRP1A is also higher than in the chimeras reconstituted with B10.D2 tg BM, whether hosts are B10.D2 or DBA/2 (Fig. 3c) Fig. 3d ) shows that the proportion of CD8 SP thymocytes in that population FIGURE 3. Differential expression of TCRP1A on DP thymocytes and frequency at which TCRP1A-expressing thymocytes are selected in the CD8 SP lineage in B10.D2 and DBA/2 backgrounds is independent of the thymic stromal cells. Thymocytes from B10.D2 and DBA/2 TCRP1A tg mice (nonreconstituted) or from B10.D2 and DBA/2 radiation chimeras reconstituted with BM from DBA/2 or B10.D2 TCRP1A tg donors were analyzed by cytofluorimetry. a, CD4 vs CD8 dot plots are shown for B10.D2 (first row) or DBA/2 (second row) hosts that received BM from tg TCRP1A DBA/2 (second column) or tg TCRP1A B10.D2 (third column) origin. CD4:CD8 ratios for SP thymocytes are shown as gray bars for tg B10.D2 or for chimeras with BM of tg B10.D2 origin, as white bars for tg DBA/2 or for chimeras with BM of tg DBA/2 origin. Hosts were B10.D2 or DBA/2 as indicated under the bars. Numbers above the dot plots indicate total thymocytes/mouse. Values are means Ϯ SD of three independent experiments. The differences in CD4:CD8 ratios between tg TCRP1A(B10.D2) and tg DBA/2 mice (p Ͻ 0.0001) or between chimeras with BM from tg B10.D2 and chimeras with BM from tg DBA/2 (p Ͻ 0.01) mice are significant, whereas those between chimeras reconstituted with the same tg BM in two distinct hosts are not. b, V␣8.3 (first row) and L d /P1A-tet (second row) staining levels are shown within the gated DP thymocyte subpopulations. Filled gray curves for B10.D2 and bold empty curves for DBA/2 correspond to the source of the thymocytes in the nonreconsituted samples, while in the reconstituted samples, they correspond to host chimeras. is also characteristic of the source of tg BM, being higher with B10.D2 BM. A correspondingly lower proportion of CD69-positive CD8 SP thymocytes is also characteristic of the DBA/2 origin of hemopoietic cells (Fig. 3e) . These results suggest that the frequency at which TCRP1A-expressing DP thymocytes are committed or selected in the CD8 SP lineage is differentially controlled in B10.D2 and DBA/2 backgrounds, irrespective of the source of thymic stromal cells.
To further evaluate whether these characteristics of TCRP1A expression are truly thymocyte-intrinsic, or may be influenced by other hemopoietic thymic cells, we established an additional series of radiation chimeras reconstituted with a mixture of TCRP1A BM cells of B10.D2 and DBA/2 origin.
Differential regulation of TCRP1A and CD3 expression in DP thymocytes is thymocyte intrinsic
A next series of radiation chimeras was constructed in which irradiated B10.D2 hosts were reconstituted with T cell-depleted BM from TCRP1A tg mice of either B10.D2 or DBA/2 background (single chimeras), or with a mixture of these two (double chimeras with a ratio of B10.D2 to DBA/2 tgBM of 1:2 or 1:4).
The CD5 allele difference between B10.D2 (CD5.2) and DBA/2 (CD5.1) allowed for a separate analysis of the thymocytes of each origin. As expected, in the single chimeras reconstituted with T cell-depleted DBA/2 tg BM, Ͼ95% of the thymocytes were stained with the anti-CD5.1 mAb, whereas in the double chimeras 69 and 79% of thymocytes were stained with this Ab when the mixture of B10.D2 to DBA/2 BM was of 1:2, or 1:4, respectively (results not shown). The observation that reconstitution of the "double" chimeras is in favor of the BM of DBA/2 origin may be related to the described higher frequency of hemopoietic stem cells within the BM (26) and higher capacity for self renewal of hemopoietic cells (27) in DBA/2 as compared with C57BL/6 mice.
Profiles of L d /P1A tetramer binding are shown on the gated CD5.1-positive and/or -negative thymocytes from each sample (Fig.  4a) . As previously shown (Fig. 3c) 43, 2.18, 2.28, and 3. 3) whether nonreconstituted TCRP1A, "single chimeras," or "double chimeras" were considered, respectively. 4a). When gating on the L d /P1A tetramer int/high subpopulations as indicated in the figure, CD8 vs CD4 dot plots (Fig. 4a, lower panel) showed a consistently lower proportion of CD8 SP thymocytes on CD5.1-positive cells originating from tg DBA/2 BM, than on the corresponding CD5.1-negative population originating from tg B10.D2 BM. Similar results were obtained after gating on CD3 high thymocytes, where CD4 to CD8 ratios were higher in CD5.1-positive thymocytes (Fig. 4b) . The fraction of CD8 SP to DP thymocytes within the CD3 high populations was also characteristically lower in the CD5.1-positive populations (Fig. 4b) .
These results indicate that the characteristic higher frequency at which TCRP1A-expressing DP thymocytes are committed or selected in the CD8 SP lineage in the B10.D2 as compared with the DBA/2 background is intrinsically controlled by the genetic make up of the differentiating thymocytes. Additional complexity in the pattern of thymocyte differentiation/selection may arise from variations in the thymic environment (28) that may include the presence of immature thymocytes with distinct differentiation potential as observed in the double chimeras (Ref. 28 and our results; see Discussion).
T cell lineage intrinsic genetic control of the representation of CD8 T cells expressing TCRP1A in peripheral organs of TCRP1A transgenic mice
T cell representation in the periphery is dependent on thymic differentiation/selection events as well as on factors controlling their exit from the thymus and their peripheral expansion/survival. The latter events may be influenced by the genetic make up of the environment, in particular, the dendritic cell component independent of the thymus. To evaluate this possibility, we analyzed the peripheral T cells in the single and double radiation chimeras constructed in irradiated B10.D2 hosts after gating (as described earlier) (Fig. 4) on CD5.1-positive and/or CD5.1-negative LN cells (Fig. 5) .
In B10.D2 hosts reconstituted with tg TCRP1A(B10.D2) BM, the low LN CD4/CD8 ratio characteristic of B10.D2 was observed, whereas reconstitution with tg TCRP1A(DBA/2) led to a high ratio characteristic of DBA/2 (Fig. 5a ).
In the double chimeras, the CD4/CD8 cell ratios were higher for CD5.1-positive T cells of DBA/2 origin than for CD5.1-negative T cells of B10.D2 origin (Fig. 5b) . The fraction of CD8 T cells that binds L d /P1A tetramer was also consistently lower when T cells were of DBA/2 origin whether in single or double chimeras (Fig.  5, a and b) .
The characteristics of inferior CD8 T-lineage selection/commitment in tg TCRP1A mice of DBA/2 as compared with B10.D2 background that are imprinted in a thymocyte autonomous fashion during thymic development are also found in the peripheral T cell population. It can be noted, however, that there may be a thymusindependent regulation of the relative expansion/homeostasis of peripheral T cells of DBA/2 vs B10.D2 origin in the irradiated host since for double chimeras composed of 69 and 79% thymocytes of DBA/2 origin, only ϳ44% of peripheral T cells were of DBA/2 origin (results not shown).
Discussion
Expression of a MHC class I-restricted TCR as a transgene in the thymus generally increases the frequency of CD8 vs CD4 lineage thymocytes so that the ratio of CD4 to CD8 lineage T cells in thymus and periphery, usually in favor of CD4, becomes reversed (21) (22) (23) . In this study, we analyzed a model in which the TCRP1A was expressed under control of regulatory sequences of the TCR␤ and TCR␣, respectively (18) . The TCRP1A was clearly selected exclusively on the CD8 lineage as indicated in the Rag-1°/°mice, as well as by the high and homogeneous expression of the tg TCR␣ chain on CD8 T cells as compared with its low and heterogeneous expression on the CD4 T cells.
The poor representation of peripheral CD8 T cells expressing tg TCRP1A in DBA/2 mice led us to evaluate whether the thymic environment could affect selection of this TCR. In particular, in addition to its expression in MHC class I-negative gametogenic tissue (29), P1A mRNA was recently detected in some medullary thymic epithelial cells thought to contribute to tolerance induction to tissue Ags (30) . Our results show that the improved selection of TCRP1A-expressing CD8 T cells in mice of the B10.D2 strain is genetically controlled in a thymocyte-intrinsic fashion, independent of the genetic make up of the thymic stroma or of non-T lineage hemopoietic cells, ruling out a role for thymic epithelium or hemopoietic and antigenic environment in preventing positive selection or inducing negative selection.
Indeed, a striking difference appeared in the expression pattern of the tg TCRP1A on DP thymocytes, depending on the genetic background. As CD3 expression followed a similar pattern as that of the TCRP1A, differences in expression of endogenous TCR␣ chains should not be responsible for this strain-dependent phenotype. In DBA/2, a homogenous TCRP1A int DP thymocyte population led to poor selection to the CD8 lineage, whereas in B10.D2, a reduced fraction of DP thymocytes expressed the TCRP1A and at lower level, yet selection to the CD8 lineage occurred more frequently in that strain. This characteristic appears to be mostly thymocyte-intrinsic as in radiation BM chimeras, the percentage of TCRP1A high cells that are CD8 SP is higher when thymocytes are of B10.D2 origin in either B10.D2 (22%) or DBA/2 (16%) hosts, than of DBA/2 origin in either B10.D2 (4%) or DBA/2 (1.3%) hosts. However, as the homologous combinations show the most extreme differences, there may be a minor component associated with the thymic context.
Thus, TCR int expression on a majority of DP thymocytes, in DBA/2 mice, does not appear appropriate for maturation to the CD8 lineage. Two main interpretations may be put forward: 1) DP TCR int thymocytes may represent "CD4-committed" thymocytes for which coengagement of TCR and CD8 does not provide the appropriate signal (in strength and duration (1, 2)) required for their differentiation; and 2) in DBA/2 mice, DP thymocytes may have an "intrinsic" property that endows low probability of selection to the CD8 lineage. This probability would not be increased by expression of a MHC class I-restricted TCR even in an appropriately selecting environment. The latter proposition would be compatible with the higher ratio of CD4 to CD8 thymocytes in DBA/2 mice as compared with "C57BL/6-based" mice, independent of the expression of a tg TCR (Ref. 20, our data, Fig. 2a) .
The relative size of the CD4 and CD8 T cell compartments is known to be genetically controlled in mice and man (20, 31, 32) . In some mouse combinations, this trait was mapped to the TCR␣ chain locus, suggesting that it was the consequence of a preference for MHC class II selection by a given array of V␣ genes characterizing a TCR␣ haplotype (33) . However, the higher CD4/CD8 T cell ratio in DBA/2 as compared with C57BL/6 mice was not linked to either TCR␣ or TCR␤ loci, and was independent of MHC haplotype (20) . It was suggested to originate in the thymus and to be controlled by thymocyte-intrinsic factors (20) , although linkage analysis also suggests that additional genes may influence CD4/ CD8 T cell ratio in the periphery vs the thymus (34) .
Candidates for genes controlling the CD4/CD8 lineage decision include lck (strength of signal) (35) , as well as the transcription factor GATA-3 and its antagonist ROG (10) . The activity of the src kinase, Lck, directly controls the strength of signal resulting from TCR/coreceptor engagement, whereas the level of GATA-3 expression depends on the strength of TCR-mediated signaling and regulates CD4/CD8 differentiation. Thus, overexpression of GATA-3 in DP thymocytes inhibits differentiation of CD8 SP thymocytes, whereas expression of its antagonist ROG enhances the development of CD8 SP thymocytes (10) . It is interesting to note that ROG also represses IL-4 gene activation in CD8 T cells (36) . Thus, a genetic background in which ROG functions more efficiently may be expected to develop more frequent CD8 lineage T cells and to be more "Th1" prone as is the case for C57BL/6-based mice (20, 37) . Other transcription factors (9, 38) or transcriptional repressors (11, 39) also influence CD4/CD8 lineage decision.
As most studies that carefully analyzed pathways of thymocyte selection (21, 22, 24, 40) and lineage commitment (5, 41, 42) were based on the C57BL/6 genetic background, it will be important to determine how polymorphism in thymocyte-intrinsic genes may affect these processes and which molecules are involved. Genometagged mice recently developed with DBA/2 as a donor and C57BL/6 as a background strain (43) may be useful for such an approach.
The comparison of gene expression in the defined DP thymocyte populations expressing a tg TCR that is selectable for the CD8-lineage but whose actual selection frequency varies depending on the strain of origin as defined in our study, may be informative in this regard. Analysis of the chromatin structure (44, 45) of the CD4 and CD8 loci in these populations may also reveal whether low frequency of transit of DP thymocytes to the CD8 lineage characterizes a population of DP thymocyte that may be "precommitted" to the CD4 lineage.
In addition to thymocyte-intrinsic genes and to the well established role of the thymic stroma in TCR-dependent selection of DP thymocytes developing thymocytes were also found to be "aware" of their neighbor thymocytes, as the frequency of differentiation of DP thymocytes to a mature lineage was influenced by the presence of "non-selectable" DP thymocytes (28) . The differences in patterns of thymic reconstitution observed in radiation chimeras reconstituted with a homogenous source of tg TCR BM (single chimeras) or with tg TCR BM from two distinct mouse strains (double chimeras) also suggest an additional complexity related to the presence of neighboring thymocytes that would require further study. Additionally, the difference in the relative efficiency of reconstitution of thymocytes and peripheral T cells in those double chimeras further indicates that distinct control mechanisms are involved in postthymic expansion/migration of mature T cells and contribute to the establishment of the useful T cell repertoire.
The poor representation of the TCRP1A CD8 T cells in DBA/2 as compared with (DBA/2 ϫ B10.D2)F 1 mice (Fig. 1a) was correlated with a lower resistance to growth of P1A-expressing tumors (results not shown). Whether differences in the efficacy of CD8 T cell selection also contribute to the higher susceptibility of DBA/2 as compared with C57BL/6-based mice in other transplanted tumor models (46) remains to be addressed.
